Vascular neurosurgery: understanding five different pathways

Aneurysm and aneurysmal subarachnoid haemorrhage

An intracranial aneurysm is an outpouching of an artery. Many unruptured aneurysms never bleed; rupture can cause subarachnoid haemorrhage, a medical emergency with risks including rebleeding, hydrocephalus, vasospasm-related ischaemia and seizures.

For an unruptured aneurysm, size, shape, growth, location, previous haemorrhage, family history, smoking, blood pressure, age and treatment risk are considered together. Treatment may be endovascular, microsurgical or observation; rupture requires rapid specialist securing when feasible.

Brain arteriovenous malformation (AVM)

An AVM is a direct high-flow connection between arteries and veins without a normal capillary bed. It may present with haemorrhage, seizure, headache or focal symptoms, or be incidental.

Management can involve observation, microsurgery, endovascular embolisation, stereotactic radiosurgery or a planned combination. Lesion architecture, previous bleeding, venous drainage, location, age and functional risk matter. Evidence does not support a universal intervention rule for every unruptured AVM.

Dural arteriovenous fistula (dAVF)

A dAVF is an abnormal connection within the dura. Symptoms can include pulse-synchronous noise, eye redness or swelling, cranial-nerve symptoms, neurological deficit or haemorrhage. The pattern of venous drainage is a central risk feature.

A fistula with cortical venous reflux generally deserves urgent specialist assessment because its behaviour differs from a low-risk fistula draining into a venous sinus. Catheter angiography often defines the architecture; treatment may be endovascular, surgical or, in selected cases, observation.

Cavernous malformation

A cavernous malformation is a cluster of thin-walled vascular spaces with slow blood flow. It may be incidental or associated with seizures, focal symptoms or haemorrhage. It is usually best characterised on MRI and is often not visible on catheter angiography.

Many asymptomatic lesions are observed. Surgery may be considered for selected accessible symptomatic lesions, recurrent haemorrhage or drug-resistant seizures when expected benefit outweighs neurological risk. Brainstem location demands particular caution.

Moyamoya angiopathy

Moyamoya causes progressive narrowing of major arteries at the brain base and formation of fragile collateral vessels. It can lead to transient ischaemic attacks, stroke, headache, seizures or haemorrhage; children and adults can present differently.

Assessment combines vascular imaging with brain and perfusion studies when appropriate. Revascularisation surgery aims to improve blood supply in selected symptomatic or haemodynamically impaired patients. Medicines may support stroke prevention in selected situations but do not reverse the arterial narrowing.

Assessment and observation

• Neurological examination and review of the exact event, previous bleeding, seizures and vascular risk factors.
• CT and CT angiography in a suspected acute haemorrhage; MRI and MR angiography for tissue and vessel detail when suitable.
• Catheter angiography when fine vessel architecture will change treatment, acknowledging its invasive risks.
• Serial non-invasive imaging for selected observed unruptured lesions, with interval based on condition and risk—not one schedule for all.
• Multidisciplinary neurovascular review involving relevant microsurgical, endovascular, stroke and radiosurgical expertise.

What a procedure is trying to achieve

Clipping or endovascular treatment aims to exclude an aneurysm from circulation. AVM or dAVF treatment aims to disconnect the abnormal shunt; partial treatment may not remove haemorrhage risk unless it is a deliberate staged plan. Cavernoma surgery removes a selected lesion, while moyamoya revascularisation provides alternative blood flow.

Every option has condition-specific risks such as stroke, bleeding, vessel injury, incomplete closure, recurrence or new neurological deficit. A technically possible procedure is not automatically the best personal choice.

Uncertainty and follow-up

Risk calculators and published series describe groups, not an individual's future. Rare architecture, family history, age and treatment expertise can change interpretation. Some vascular lesions change over time, while a stable scan does not rule out every clinical concern.

Follow-up should record neurological function, seizures, cognition, headache impact and blood-flow or vessel status where relevant. No treatment can guarantee that stroke, bleeding or recurrence will never occur.